Literature DB >> 15863746

Distinctive neurocognitive effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in major depression.

Svenja C Schulze-Rauschenbach1, Uta Harms, Thomas E Schlaepfer, Wolfgang Maier, Peter Falkai, Michael Wagner.   

Abstract

BACKGROUND: Studies have compared electroconvulsive therapy (ECT) and repetitive transcranial magnetic stimulation (rTMS) with regard to clinical efficacy in the treatment of depression, but no study has yet addressed the differential impact on cognition. AIMS: To compare the neurocognitive effects of unilateral ECT and rTMS.
METHOD: Thirty patients with treatment-refractory non-psychotic major depression received an average of ten treatments with either unilateral ECT or left prefrontal rTMS and were assessed for objective and subjective cognitive impairments before and about a week after treatment.
RESULTS: Treatment response was comparable (46% of the ECT group and 44% of the rTMS group showed a reduction of 50% or more in Hamilton Rating Scale for Depression scores). In patients treated with rTMS, cognitive performance remained constant or improved and memory complaints alleviated, whereas in the ECT group memory recall deficits emerged and memory complaints remained.
CONCLUSIONS: In contrast to unilateral ECT, rTMS has no adverse memory effects.

Entities:  

Mesh:

Year:  2005        PMID: 15863746     DOI: 10.1192/bjp.186.5.410

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  22 in total

Review 1.  Brain stimulation in psychiatry and its effects on cognition.

Authors:  Kate E Hoy; Paul B Fitzgerald
Journal:  Nat Rev Neurol       Date:  2010-04-06       Impact factor: 42.937

2.  Neuromodulation and Transcranial Mag Netic Stimulation (TMS): A 21st Century Paradigm for Therapeutics in Psychiatry.

Authors:  John P O'Reardon; Andrew D Peshek; Rocio Romero; Pilar Cristancho
Journal:  Psychiatry (Edgmont)       Date:  2006-01

3.  Repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex enhances working memory.

Authors:  Yasaman Bagherzadeh; Anahita Khorrami; Mohammad Reza Zarrindast; Seyed Vahid Shariat; Dimitrios Pantazis
Journal:  Exp Brain Res       Date:  2016-02-16       Impact factor: 1.972

4.  Repetitive transcranial magnetic stimulation: a psychiatric treatment of the future?

Authors:  H O'Connell; R Goggins; P G Doyle
Journal:  Ir J Med Sci       Date:  2006 Oct-Dec       Impact factor: 1.568

Review 5.  Neuromodulation for treatment-refractory major depressive disorder.

Authors:  Nir Lipsman; Tejas Sankar; Jonathan Downar; Sidney H Kennedy; Andres M Lozano; Peter Giacobbe
Journal:  CMAJ       Date:  2013-07-29       Impact factor: 8.262

Review 6.  Can noninvasive brain stimulation enhance cognition in neuropsychiatric disorders?

Authors:  Asli Demirtas-Tatlidede; Andrew M Vahabzadeh-Hagh; Alvaro Pascual-Leone
Journal:  Neuropharmacology       Date:  2012-06-28       Impact factor: 5.250

Review 7.  Neuropsychologic effects of neuromodulation techniques for treatment-resistant depression: a review.

Authors:  Jared L Moreines; Shawn M McClintock; Paul E Holtzheimer
Journal:  Brain Stimul       Date:  2010-02-11       Impact factor: 8.955

8.  Agomelatine in unipolar depression in clinical practice: a retrospective chart review.

Authors:  Julie Langan; Polash Shajahan; Daniel Martin; Rebecca Carleton
Journal:  Ther Adv Psychopharmacol       Date:  2011-12

9.  The long-term impact of treatment with electroconvulsive therapy on discrete memory systems in patients with bipolar disorder.

Authors:  Glenda MacQueen; Caroline Parkin; Michael Marriott; Helen Bégin; Gary Hasey
Journal:  J Psychiatry Neurosci       Date:  2007-07       Impact factor: 6.186

10.  No change in neuropsychological functioning after receiving repetitive transcranial magnetic stimulation treatment for major depression.

Authors:  Chandra Wajdik; Keith H Claypoole; Walid Fawaz; Paul E Holtzheimer; John Neumaier; David L Dunner; David R Haynor; Peter Roy-Byrne; David H Avery
Journal:  J ECT       Date:  2014-12       Impact factor: 3.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.